Mesothelioma, Small Cell Lung Cancer, NSCLC Clinical Trial
Official title:
Mayo Clinic Validation of the MiCK Assay
Testing Mayo Clinic cancer patients with the results being correlated with prior patient therapy, performance status, and extent of disease.
This study will be conducted in two phases.
During the Feasibility Phase, specimens from any tumor will be sent to the central DiaTech
MiCK assay laboratory to determine the ease of sample acquisition, processing, transport,
and assay interpretation.
Once DiaTech has completed analyses for the feasibility phase specimens and has confirmed
that the sample acquisition, processing, transport, and assay interpretation are
appropriate, we will proceed with the Demonstration Phase.
During the Mesothelioma Demonstration Phase, 20 mesothelioma samples will be assayed and the
results will be correlated with prior patient therapy, performance status, and extent of
disease.
;
Observational Model: Cohort, Time Perspective: Prospective